The treatments are a good solution for Indians who can afford them, Goel added
Metformin is commonly used as first-line therapy unless contraindicated or poorly tolerated, but the addition of glucose-lowering therapies with different mechanisms of action is usually needed to provide adequate glycemic control [1,2,3], with the choice of agent being dependent on multiple factors, such as cost and the presence of comorbidities [1]
Semaglutide itself requires caution in patients with a history of pancreatitis, severe GI disease, or medullary thyroid carcinoma
Generalized skin sensitivity is not listed as a recognized adverse effect in FDA prescribing information for semaglutide
Available from: Pajecki D, Halpern A, Cercato C, et al